Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Clinical and laboratory characteristics of the non-obese subjects (BMI <25 kg/m 2 )

From: Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study

  Gout Healthy P
  (n = 38) (n = 150)  
Age, years 52.6 ± 9.7 49.2 ± 10.8 0.06
Body mass index, kg/m2 23.4 (2.0) 22.7 (2.4) 0.127*
Visceral fat area, cm2 98.7 ± 19.3 91.0 ± 16.7 0.016
Visceral fat obesity, VFA ≥100 cm2 18 (47.4%) 41 (27.3%) 0.017
Waist circumference, cm 84.7 (6.8) 79.7 (8.5) 0.001*
Hip circumference, cm 92.9 ± 4.9 92.4 ± 3.7 0.403
Total fat mass, kg 14.3 (4.5) 13.5 (4.1) 0.271*
Total fat percentage, % 21.1 ± 4.7 20.4 ± 3.8 0.295
Systolic blood pressure, mmHg 122.5 ± 13.9 117.5 ± 13.1 0.049
Diastolic blood pressure, mmHg 80.0 (14.5) 74.0 (15.0) 0.070*
Uric acid, mg/dL 7.9 (1.3) 6.0 (1.3) <0.001*
Total cholesterol, mg/dL 193.1 ± 33.8 190.5 ± 27.5 0.746
Triglyceride, mg/dL 127.0 (94.0) 81.0 (52.0) <0.001*
High-density lipoprotein, mg/dL 46.5 (16.0) 51.0 (15.0) 0.008*
Low-density lipoprotein, mg/dL 114.5 (37.0) 115.0 (37.0) 0.919*
Glucose, mg/dL 97.3 ± 13.0 89.0 ± 6.8 <0.001
  1. *Non-parametric Mann-Whitney U-test was used.
  2. mean ± standard deviation or median (interquartile range).